{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:48:48Z","timestamp":1782175728447,"version":"3.54.5"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,6,22]]},"DOI":"10.7759\/cureus.111315","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:09:16Z","timestamp":1782173356000},"source":"Crossref","is-referenced-by-count":0,"title":["A Proposed Clinical Validation Pathway for the Artificial Intelligence-Driven Integrated Risk Assessment of Cardiovascular Disease (AIRA-CVD): A Translational Framework Integrating Inflammatory Biomarkers, Histopathology, and Machine Learning"],"prefix":"10.7759","author":[{"given":"CFC","family":"Ogbuefi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Centers for Disease Control and Prevention. Heart disease facts. (2024). Accessed. May 18, 2026: https:\/\/www.cdc.gov\/heart-disease\/data-research\/facts-stats\/index.html."},{"key":"ref2","unstructured":"Centers for Disease Control and Prevention. Fast facts. health and economic costs of chronic conditions. (2024). Accessed: May 18, 2026: https:\/\/www.cdc.gov\/chronic-disease\/data-research\/facts-stats\/index.html."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001303","article-title":"2025 heart disease and stroke statistics: a report of US and global data from the American Heart Association","volume":"151","author":"Martin SS","year":"2025","unstructured":"Martin SS, Aday AW, Allen NB, et al.. 2025 heart disease and stroke statistics: a report of US and global data from the American Heart Association. Circulation. 2025, 151:e41-660. 10.1161\/CIR.0000000000001303","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000678","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"140","author":"Arnett DK","year":"2019","unstructured":"Arnett DK, Blumenthal RS, Albert MA, et al.. 2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019, 140:e596-646. 10.1161\/CIR.0000000000000678","journal-title":"Circulation"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/nature01323","article-title":"Inflammation in atherosclerosis","volume":"420","author":"Libby P","year":"2002","unstructured":"Libby P. Inflammation in atherosclerosis. Nature. 2002, 420:868-74. 10.1038\/nature01323","journal-title":"Nature"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2007.02.052","article-title":"C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus","volume":"49","author":"Ridker PM","year":"2007","unstructured":"Ridker PM. C-reactive protein and the prediction of cardiovascular events among those at intermediate risk: moving an inflammatory hypothesis toward consensus. J Am Coll Cardiol. 2007, 49:2129-38. 10.1016\/j.jacc.2007.02.052","journal-title":"J Am Coll Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker PM","year":"2017","unstructured":"Ridker PM, Everett BM, Thuren T, et al.. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. 2017, 377:1119-31. 10.1056\/nejmoa1707914","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker PM","year":"2008","unstructured":"Ridker PM, Danielson E, Fonseca FA, et al.. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008, 359:2195-207. 10.1056\/NEJMoa0807646","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1056\/nejmra1814259","article-title":"Machine learning in medicine","volume":"380","author":"Rajkomar A","year":"2019","unstructured":"Rajkomar A, Dean J, Kohane I. Machine learning in medicine. N Engl J Med. 2019, 380:1347-58. 10.1056\/nejmra1814259","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0300-7","article-title":"High-performance medicine: the convergence of human and artificial intelligence","volume":"25","author":"Topol EJ","year":"2019","unstructured":"Topol EJ. High-performance medicine: the convergence of human and artificial intelligence. Nat Med. 2019, 25:44-56. 10.1038\/s41591-018-0300-7","journal-title":"Nat Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2018.03.521","article-title":"Artificial intelligence in cardiology","volume":"71","author":"Johnson KW","year":"2018","unstructured":"Johnson KW, Torres Soto J, Glicksberg BS, et al.. Artificial intelligence in cardiology. J Am Coll Cardiol. 2018, 71:2668-79. 10.1016\/j.jacc.2018.03.521","journal-title":"J Am Coll Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.106615","article-title":"Artificial Intelligence-Driven Integrated Risk Assessment of Cardiovascular Disease (AIRA-CVD): a technical framework incorporating inflammatory biomarker signatures and histopathological vascular remodeling","volume":"18","author":"Ogbuefi C","year":"2026","unstructured":"Ogbuefi C. Artificial Intelligence-Driven Integrated Risk Assessment of Cardiovascular Disease (AIRA-CVD): a technical framework incorporating inflammatory biomarker signatures and histopathological vascular remodeling. Cureus. 2026, 18:e106615. 10.7759\/cureus.106615","journal-title":"Cureus"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.103995","article-title":"Ethical governance of artificial intelligence in cardiovascular disease management: a health policy perspective","volume":"18","author":"Ogbuefi C","year":"2026","unstructured":"Ogbuefi C, Ezika OL, Egbunike JO, Ogbuefi KE. Ethical governance of artificial intelligence in cardiovascular disease management: a health policy perspective. Cureus. 2026, 18:e103995. 10.7759\/cureus.103995","journal-title":"Cureus"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.109627","article-title":"Modifiable lifestyle determinants of hypertension and cardiovascular risk in southeastern Nigeria: a narrative review from a socioecological perspective","volume":"18","author":"Ogbuefi C","year":"2026","unstructured":"Ogbuefi C, Ezika O, Ogbuefi K, Frank-Okeke NN. Modifiable lifestyle determinants of hypertension and cardiovascular risk in southeastern Nigeria: a narrative review from a socioecological perspective. Cureus. 2026, 18:e109627. 10.7759\/cureus.109627","journal-title":"Cureus"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/nejm199901143400207","article-title":"Atherosclerosis \u2014 an inflammatory disease","volume":"340","author":"Ross R","year":"1999","unstructured":"Ross R. Atherosclerosis \u2014 an inflammatory disease. N Engl J Med. 1999, 340:115-26. 10.1056\/nejm199901143400207","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.10.065","article-title":"Pathology of the vulnerable plaque","volume":"47","author":"Virmani R","year":"2006","unstructured":"Virmani R, Burke AP, Farb A, Kolodgie FD. Pathology of the vulnerable plaque. J Am Coll Cardiol. 2006, 47:C13-8. 10.1016\/j.jacc.2005.10.065","journal-title":"J Am Coll Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1126\/science.aax2342","article-title":"Dissecting racial bias in an algorithm used to manage the health of populations","volume":"366","author":"Obermeyer Z","year":"2019","unstructured":"Obermeyer Z, Powers B, Vogeli C, Mullainathan S. Dissecting racial bias in an algorithm used to manage the health of populations. Science. 2019, 366:447-53. 10.1126\/science.aax2342","journal-title":"Science"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMp1714229","article-title":"Implementing machine learning in health care \u2014 addressing ethical challenges","volume":"378","author":"Char DS","year":"2018","unstructured":"Char DS, Shah NH, Magnus D. Implementing machine learning in health care \u2014 addressing ethical challenges. N Engl J Med. 2018, 378:981-3. 10.1056\/NEJMp1714229","journal-title":"N Engl J Med"},{"key":"ref19","unstructured":"WHO. Ethics and governance of artificial intelligence for health. (2021). Accessed. May 18, 2026: https:\/\/www.who.int\/publications\/i\/item\/9789240029200."},{"key":"ref20","unstructured":"Million Hearts. About Million Hearts\u00ae 2027. (2024). Accessed. May 18, 2026: https:\/\/millionhearts.hhs.gov\/about-million-hearts\/index.html."},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.15212\/cvia.2026.0001","article-title":"Emerging novel biomarkers in acute coronary syndrome management: insights and future directions","volume":"11","author":"Mittal A","year":"2026","unstructured":"Mittal A, Singhal K, Djoumsie EBG, Sharma YP, Batta A. Emerging novel biomarkers in acute coronary syndrome management: insights and future directions. Cardiovasc Innov Appl. 2026, 11:10.15212\/cvia.2026.0001","journal-title":"Cardiovasc Innov Appl"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.2147\/VHRM.S590502","article-title":"Artificial intelligence for cardiovascular risk prediction: an umbrella review of applications and translational challenges","volume":"22","author":"Parizad R","year":"2026","unstructured":"Parizad R, Hatwal J, Brar A, Desai R, Batta A, Mohan B. Artificial intelligence for cardiovascular risk prediction: an umbrella review of applications and translational challenges. Vasc Health Risk Manag. 2026, 22:590502. 10.2147\/VHRM.S590502","journal-title":"Vasc Health Risk Manag"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/506699-a-proposed-clinical-validation-pathway-for-the-artificial-intelligence-driven-integrated-risk-assessment-of-cardiovascular-disease-aira-cvd-a-translational-framework-integrating-inflammatory-biomarkers-histopathology-and-machine-learning","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:09:19Z","timestamp":1782173359000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/506699-a-proposed-clinical-validation-pathway-for-the-artificial-intelligence-driven-integrated-risk-assessment-of-cardiovascular-disease-aira-cvd-a-translational-framework-integrating-inflammatory-biomarkers-histopathology-and-machine-learning"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":22,"URL":"https:\/\/doi.org\/10.7759\/cureus.111315","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,22]]}}}